Baird Financial Group, Inc. Heron Therapeutics, Inc. Transaction History

Baird Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $297,037 - $637,700	-64,155 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.35 - $12.6 $48,597 - $73,332	5,820 Added 9.98%	64,155 $586,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $116,768 - $172,905	11,527 Added 24.63%	58,335 $624,000
Q2 2021 Aug 11, 2021	BUY	$13.27 - $18.48 $496,709 - $691,724	37,431 Added 399.18%	46,808 $726,000
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $23,304 - $45,945	-2,140 Reduced 18.58%	9,377 $220,000
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $21,892 - $52,558	2,140 Added 22.82%	11,517 $135,000
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $163,347 - $249,521	9,377 New	9,377 $220,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.